Soumya S. Ray

2.9k citations

41 papers · 2.2k indexed · h-index 27

Co-authors: Peter T. Lansbury Gregory D. Cuny Richard J. Nowak Robert H. BrownMin LiuP. Balaram Hemalatha Balaram Brian D. Hellmig
Topics: Parkinson's Disease Mechanisms and Treatments (7 papers)Protein Structure and Dynamics (6 papers)Computational Drug Discovery Methods (6 papers)
Cited by: Virology Neurology Molecular Biology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Molecular Cell
Partner nations: United States India Spain

In The Last Decade

Soumya S. Ray

41 papers receiving 2.1k citations

Peers

Countries citing papers authored by Soumya S. Ray

Since Specialization

Citations

This map shows the geographic impact of Soumya S. Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soumya S. Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soumya S. Ray more than expected).

Fields of papers citing papers by Soumya S. Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soumya S. Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soumya S. Ray. The network helps show where Soumya S. Ray may publish in the future.

Co-authorship network of co-authors of Soumya S. Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Soumya S. Ray. A scholar is included among the top collaborators of Soumya S. Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soumya S. Ray. Soumya S. Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing drug design by merging generative AI with a physics-based active learning framework 2025 ·Communications Chemistry ·(unknown),(unknown),Lucía Díaz,Marek Orzechowski,(unknown),(unknown),(unknown),(unknown),Ajay Yekkirala,Soumya S. Ray,Vı́ctor Guallar	2
2	Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates 2023 ·Journal of Medicinal Chemistry ·Jeremy R. Duvall,Joshua D. Thomas,Raghida A. Bukhalid,(unknown),K. W. Bentley,Scott D. Collins,Timothy K. Eitas,Brian Jones,(unknown),(unknown),Marina Protopopova,Soumya S. Ray,Elena Ter‐Ovanesyan,Ling Xu,Liping Yang,(unknown),Marc Damelin,Dorin Toader,Timothy B. Lowinger	32
3	Targeted Degradation of the Oncogenic Phosphatase SHP2 2021 ·Biochemistry ·Vidyasiri Vemulapalli,Katherine A. Donovan,T.C.M. Seegar,Julia M. Rogers,Munhyung Bae,Ryan J. Lumpkin,(unknown),Matthew T. Henke,Soumya S. Ray,Eric S. Fischer,Gregory D. Cuny,Stephen C. Blacklow	32
4	Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors 2020 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Marco Mazzonna,Debora Russo,Ilaria Penna,Maria Summa,Sine Mandrup Bertozzi,Natalia Realini,(unknown),Marco Migliore,Giuliana Ottonello,Min Liu,Peter T. Lansbury,Andrea Armirotti,Rosalia Bertorelli,Soumya S. Ray,Renato T. Skerlj,Rita Scarpelli	13
5	Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations 2018 ·Communications Biology ·Kevin Hauser,Christopher Negron,Steven K. Albanese,Soumya S. Ray,Thomas Steinbrecher,Robert Abel,John D. Chodera,Lingle Wang	64
6	Activation loop targeting strategy for design of receptor-interacting protein kinase 2 (RIPK2) inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Chalada Suebsuwong,Daniel M. Pinkas,Soumya S. Ray,Joshua C. Bufton,Bing Dai,Alex N. Bullock,Alexei Degterev,Gregory D. Cuny	18
7	Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer’s Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data 2017 ·CNS Drugs ·Petr Kočiš,Martin Tolar,Yongxin Yu,William Sinko,Soumya S. Ray,Kaj Blennow,Howard Fillit,John A. Hey	75
8	Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors 2015 ·Chemistry & Biology ·Peter Canning,(unknown),Tobias Schwerd,Matouš Hrdinka,Jenny L. Maki,Danish Saleh,Chalada Suebsuwong,Soumya S. Ray,Paul E. Brennan,Gregory D. Cuny,Holm H. Uhlig,Mads Gyrd‐Hansen,Alexei Degterev,Alex N. Bullock	77
9	Discovery of LRRK2 inhibitors using sequential in silico joint pharmacophore space (JPS) and ensemble docking 2015 ·Bioorganic & Medicinal Chemistry Letters ·Christian A. Lang,Soumya S. Ray,Min Liu,Ambuj K. Singh,Gregory D. Cuny	19
10	The Parkinson Disease-linked LRRK2 Protein Mutation I2020T Stabilizes an Active State Conformation Leading to Increased Kinase Activity 2014 ·Journal of Biological Chemistry ·Soumya S. Ray,Samantha Bender,(unknown),Regina Lin,Marcie A. Glicksman,Min Liu	30
11	Enzymatic Characterization of ER Stress-Dependent Kinase, PERK, and Development of a High-Throughput Assay for Identification of PERK Inhibitors 2014 ·SLAS DISCOVERY ·Dariusz Pytel,Kathleen Seyb,Min Liu,Soumya S. Ray,John Concannon,Mickey Huang,Gregory D. Cuny,J. Alan Diehl,Marcie A. Glicksman	22
12	Structure–activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH 2012 ·Bioorganic & Medicinal Chemistry Letters ·Sivapriya Kirubakaran,Suresh Kumar Gorla,Lisa Sharling,Minjia Zhang,Xiaoping Liu,Soumya S. Ray,Iain Macpherson,Boris Striepen,Lizbeth Hedstrom,Gregory D. Cuny	43
13	Structure–activity relationship study of beta-carboline derivatives as haspin kinase inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Gregory D. Cuny,(unknown),Debasis Patnaik,Jifeng Liu,Xiangjie Lin,(unknown),Soumya S. Ray,Jun Xian,Marcie A. Glicksman,Ross L. Stein,Jonathan M.G. Higgins	62
14	Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation 2005 ·Proceedings of the National Academy of Sciences ·Soumya S. Ray,Richard J. Nowak,Robert H. Brown,Peter T. Lansbury	121
15	Crystal Structure of the Flagellar σ/Anti-σ Complex σ28/FlgM Reveals an Intact σ Factor in an Inactive Conformation 2004 ·Molecular Cell ·(unknown),Soumya S. Ray,Seth A. Darst	99
16	X‐ray structure of an M. jannaschii DNA‐binding protein: Implications for antibiotic resistance in S. aureus 2002 ·Proteins Structure Function and Bioinformatics ·Soumya S. Ray,J.B. Bonanno,Hua Chen,Hermı́nia de Lencastre,Shangwei Wu,Alexander Tomasz,S.K. Burley	19
17	Cocrystal Structures of Diaminopimelate Decarboxylase 2002 ·Structure ·Soumya S. Ray,J.B. Bonanno,K.R. Rajashankar,Mariana G. Pinho,(unknown),Hermı́nia de Lencastre,Alexander Tomasz,S.K. Burley	47
18	Unusual stability of a multiply nicked form of Plasmodium falciparum triosephosphate isomerase 1999 ·Chemistry & Biology ·Soumya S. Ray,Hemalatha Balaram,P. Balaram	13
19	Disulfide engineering at the dimer interface of lactobacillus casei thymidylate synthase: Crystal structure of the T155C/E188C/C244T mutant 1999 ·Protein Science ·(unknown),(unknown),Soumya S. Ray,B. Gopal,Srinivasan Parthasarathy,Daniel V. Santi,P. Balaram,M.R.N. Murthy	17
20	Triosephosphate isomerase from Plasmodium falciparum:. the crystal structure provides insights into antimalarial drug design 1997 ·Structure ·(unknown),Soumya S. Ray,Rajesh S. Gokhale,(unknown),Hemalatha Balaram,P. Balaram,(unknown)	105

About Soumya S. Ray

Soumya S. Ray is a scholar working on Neurology, Molecular Medicine and Molecular Biology, having authored 41 papers that have together received 2.2k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (7 papers), Protein Structure and Dynamics (6 papers) and Computational Drug Discovery Methods (6 papers). The work is most often cited by research in Virology (236 citations), Neurology (343 citations) and Molecular Biology (1.4k citations). Soumya S. Ray has collaborated with scholars based in United States, India and Spain. Frequent co-authors include Peter T. Lansbury, Gregory D. Cuny, Richard J. Nowak, Robert H. Brown, Min Liu, P. Balaram, Hemalatha Balaram, Brian D. Hellmig, S.J. Gamblin and J S Culp. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact